|
1
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham D, Starling N, Rao S, Iveson T,
Nicolson M, Coxon F, Middleton G, Daniel F, Oates J and Norman AR:
Upper Gastrointestinal Clinical Studies Group of the National
Cancer Research Institute of the United Kingdom: Capecitabine and
oxaliplatin for advanced esophagogastric cancer. N Engl J Med.
358:36–46. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Niibe Y and Chang JY: Novel insights of
oligometastases and oligo-recurrence and review of the literature.
Pulm Med. 2012:2610962012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niibe Y and Hayakawa K: Oligometastases
and oligo-recurrence: The new era of cancer therapy. Jpn J Clin
Oncol. 40:107–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takeuchi H, Saikawa Y, Oyama T, Ozawa S,
Suda K, Wada N, Takahashi T, Nakamura R, Shigematsu N, Ando N, et
al: Factors influencing the long-term survival in patients with
esophageal cancer who underwent esophagectomy after
chemoradiotherapy. World J Surg. 34:277–284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Swisher SG, Wynn P, Putnam JB, Mosheim MB,
Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA
and Walsh GL: Salvage esophagectomy for recurrent tumors after
definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg.
123:175–183. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Journo XB and Thomas PA: Current
management of esophageal cancer. J Thorac Dis. 6 Suppl 2:253–264.
2014.
|
|
8
|
Ota K: Nedaplatin. Gan To Kagaku Ryoho.
23:379–387. 1996.(In Japanese). PubMed/NCBI
|
|
9
|
Tsuda T, Inaba H, Miyazaki A, Izawa N,
Hirakawa M, Watanabe Y, Kitajima S, Hoshikawa Y, Gomi H, Kimura M
and Itoh F: Prospective study of definitive chemoradiotherapy with
S-1 and nedaplatin in patients with stage II/III (non-T4)
esophageal cancer. Esophagus. 8:45–51. 2011. View Article : Google Scholar
|
|
10
|
Yamashita H, Haga A, Takenaka R, Kiritoshi
T, Okuma K, Ohtomo K and Nakagawa K: Efficacy and feasibility of
ambulatory treatment-based monthly nedaplatin plus S-1 in
definitive or salvage concurrent chemoradiotherapy for early,
advanced, and relapsed esophageal cancer. Radiat Oncol. 11:42016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y,
Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal
cancer in Japan and China. J Epidemiol. 23:233–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou ZG, Zhen CJ, Bai WW, Zhang P, Qiao
XY, Liang JL, Gao XS and Wang SS: Salvage radiotherapy in patients
with local recurrent esophageal cancer after radical
radiochemotherapy. Radiat Oncol. 10:542015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fakhrian K, Gamisch N, Schuster T, Thamm
R, Molls M and Geinitz H: Salvage radiotherapy in patients with
recurrent esophageal carcinoma. Strahlenther Onkol. 188:136–142.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim YS, Lee CG, Kim KH, Kim T, Lee J, Cho
Y and Koom WS: Re-irradiation of recurrent esophageal cancer after
primary definitive radiotherapy. Radiat Oncol J. 30:182–188. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tachimori Y, Kanamori N, Uemura N,
Hokamura N, Igaki H and Kato H: Salvage esophagectomy after
high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
J Thorac Cardiovasc Surg. 137:49–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Lu Y, Wang Y, Yang H, Xia Y, Chen
M, Song H, Li T, Li D, Wang J, et al: Comparison of salvage
chemoradiation versus salvage surgery for recurrent esophageal
squamous cell carcinoma after definitive radiochemotherapy or
radiotherapy alone. Dis Esophagus. 27:134–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beitler JJ, Zhang Q, Fu KK, Trotti A,
Spencer SA, Jones CU, Garden AS, Shenouda G, Harris J and Ang KK:
Final results of local-regional control and late toxicity of RTOG
9003: A randomized trial of altered fractionation radiation for
locally advanced head and neck cancer. Int J Radiat Oncol Biol
Phys. 89:13–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mohiuddin M, Marks G and Marks J:
Long-term results of reirradiation for patients with recurrent
rectal carcinoma. Cancer. 95:1144–1150. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okamoto Y, Murakami M, Yoden E, Sasaki R,
Okuno Y, Nakajima T and Kuroda Y: Reirradiation for locally
recurrent lung cancer previously treated with radiation therapy.
Int J Radiat Oncol Biol Phys. 52:390–396. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Watkins JM, Shirai KS, Wahlquist AE,
Stuart RK, Chaudhary UB, Garrett-Mayer E, Day TA, Gillespie MB and
Sharma AK: Toxicity and survival outcomes of hyperfractionated
split-course reirradiation and daily concurrent chemotherapy in
locoregionally recurrent, previously irradiated head and neck
cancers. Head Neck. 31:493–502. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niibe Y, Karasawa K, Mitsuhashi T and
Tanaka Y: Hyperfractionated radiation therapy for hypopharyngeal
carcinoma compared with conventional radiation therapy: Local
control, laryngeal preservation and overall survival. Jpn J Clin
Oncol. 33:450–455. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niibe Y, Karasawa K, Mitsuhashi T,
Miyashita H and Tanaka Y: Hyperfractionated radiation therapy for
oropharyngeal carcinoma in a Japanese population. Jpn J Clin Oncol.
34:312–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
